The effects of circumcision on the penis microbiome

PLoS ONE

Volumn 5, Issue 1, 2010, Pages

  Price, Lance B ^a   Liu, Cindy M ^a,b   Johnson, Kristine E ^c   Aziz, Maliha ^a   Lau, Matthew K ^b   Bowers, Jolene ^a   Ravel, Jacques ^d   Keim, Paul S ^a,b   Serwadda, David ^e   Wawer, Maria J ^f   Gray, Ronald H ^f  

^a TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^b NORTHERN ARIZONA UNIVERSITY   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e MAKERERE UNIVERSITY   (Uganda)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA 16S; BACTERIAL RNA;

ADOLESCENT; ADULT; AEROBIC BACTERIUM; ANAEROBIC BACTERIUM; ANAEROCOCCUS; ANOXIA; ARTICLE; BAYESIAN LEARNING; CD4 LYMPHOCYTE COUNT; CELL ACTIVATION; CIRCUMCISION; CLINICAL TRIAL; CLOSTRIDIACEAE; CLOSTRIDIALES; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FINEGOLDIA; GENE SEQUENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LANGERHANS CELL; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MICROBIOME; MICROENVIRONMENT; MICROFLORA; MUCOSAL IMMUNITY; NONHUMAN; OXALOBACTERACEAE; PENIS; PEPTONIPHILUS; PREPUCE; PREVOTELLACEAE; PSEUDOMONADACEAE; PYROSEQUENCING; RANDOMIZED CONTROLLED TRIAL; SEQUENCE TAGGED SITE; SEXUALLY TRANSMITTED DISEASE; TAXONOMY; UGANDA; VAGINITIS; BAYES THEOREM; CLASSIFICATION; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; SPECIES DIFFERENCE;

ANAEROCOCCUS; BACTERIA (MICROORGANISMS); CLOSTRIDIALES; FINEGOLDIA; HUMAN HERPESVIRUS 2; HUMAN PAPILLOMAVIRUS; PEPTONIPHILUS; PREVOTELLA; PREVOTELLACEAE; PSEUDOMONADACEAE;

BACTERIA, ANAEROBIC; BAYES THEOREM; CIRCUMCISION, MALE; HUMANS; MALE; PENIS; RNA, BACTERIAL; RNA, RIBOSOMAL, 16S; SPECIES SPECIFICITY;

EID: 77649175959     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008422     Document Type: Article

References (67)

1. Bailey RC, Moses S, Parker CB, Agot K, Maclean I, et al. (2007) Male circumcision for HIV prevention in young men in kisumu, kenya: A randomised controlled trial. Lancet 369(9562): 643-656.
2. Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, et al. (2007) Male circumcision for HIV prevention in men in rakai, uganda: A randomised trial. Lancet 369(9562): 657-666.
3. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, et al. (2005) Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: The ANRS 1265 trial. PLoS Med 2(11): e298.
4. Tobian AA, Serwadda D, Quinn TC, Kigozi G, Gravitt PE, et al. (2009) Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med 360(13): 1298-1309.
5. Gray RH, Kigozi G, Serwadda D, Makumbi F, Nalugoda F, et al. (2009) The effects of male circumcision on female partners' genital tract symptoms and vaginal infections in a randomized trial in rakai, uganda. Am J Obstet Gynecol 200(1): 42.e1-42.e7.
6. Mahiane SG, Legeai C, Taljaard D, Latouche A, Puren A, et al. (2009) Transmission probabilities of HIV and herpes simplex virus type 2, effect of male circumcision and interaction: A longitudinal study in a township of south africa. AIDS 23(3): 377-383.
7. WHO (2007) Male circumcision for HIV prevention: Research implications for policy and programming. WHO/UNAIDS technical consultation, 6-8 march 2007. conclusions and recommendations (excerpts). Reprod Health Matters 15(29): 11-14.
8. Galvin SR, Cohen MS (2004) The role of sexually transmitted diseases in HIV transmission. Nat Rev Microbiol 2(1): 33-42.
9. de Jong MA, Geijtenbeek TB (2009) Human immunodeficiency virus-1 acquisition in genital mucosa: Langerhans cells as key-players. J Intern Med 265(1): 18-28.
10. Donoval BA, Landay AL, Moses S, Agot K, Ndinya-Achola JO, et al. (2006) HIV-1 target cells in foreskins of african men with varying histories of sexually transmitted infections. Am J Clin Pathol 125(3): 386-391.
11. de Witte L, Nabatov A, Geijtenbeek TB (2008) Distinct roles for DC-SIGN+-dendritic cells and langerhans cells in HIV-1 transmission. Trends Mol Med 14(1): 12-19.
12. Wu L, KewalRamani VN (2006) Dendritic-cell interactions with HIV: Infection and viral dissemination. Nat Rev Immunol 6(11): 859-868.
13. de Witte L, Nabatov A, Pion M, Fluitsma D, de Jong MA, et al. (2007) Langerin is a natural barrier to HIV-1 transmission by langerhans cells. Nat Med 13(3): 367-371.
14. Fahrbach KM, Barry SM, Ayehunie S, Lamore S, Klausner M, et al. (2007) Activated CD34-derived langerhans cells mediate transinfection with human immunodeficiency virus. J Virol 81(13): 6858-6868.
15. Peiser M, Koeck J, Kirschning CJ, Wittig B, Wanner R (2008) Human langerhans cells selectively activated via toll-like receptor 2 agonists acquire migratory and CD4+T cell stimulatory capacity. J Leukoc Biol 83(5): 1118-1127.
16. Kawamura T, Kurtz SE, Blauvelt A, Shimada S (2005) The role of langerhans cells in the sexual transmission of HIV. J Dermatol Sci 40(3): 147-155.
17. de Jong MA, de Witte L, Oudhoff MJ, Gringhuis SI, Gallay P, et al. (2008) TNF-alpha and TLR agonists increase susceptibility to HIV-1 transmission by human langerhans cells ex vivo. J Clin Invest 118(10): 3440-3452.
18. Ogawa Y, Kawamura T, Kimura T, Ito M, Blauvelt A, et al. (2009) Grampositive bacteria enhance HIV-1 susceptibility in langerhans cells, but not in dendritic cells, via toll-like receptor activation. Blood 113(21): 5157-5166.
19. Patterson BK, Landay A, Siegel JN, Flener Z, Pessis D, et al. (2002) Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture. Am J Pathol 161(3): 867-873.
20. McCoombe SG, Short RV (2006) Potential HIV-1 target cells in the human penis. AIDS 20(11): 1491-1495.
21. Zhou X, Brown CJ, Abdo Z, Davis CC, Hansmann MA, et al. (2007) Differences in the composition of vaginal microbial communities found in healthy caucasian and black women. ISME J 1(2): 121-133.
22. Fredricks DN, Fiedler TL, Marrazzo JM (2005) Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 353(18): 1899-1911.
23. Price LB, Liu CM, Melendez JH, Frankel YM, Engelthaler D, et al. (2009) Community analysis of chronic wound bacteria using 16S rRNA gene-based pyrosequencing: Impact of diabetes and antibiotics on chronic wound microbiota. PLoS One 4(7): e6462.
24. Cole JR, Wang Q, Cardenas E, Fish J, Chai B, et al. (2009) The ribosomal database project: Improved alignments and new tools for rRNA analysis. Nucleic Acids Res 37(Database issue): D141-5.
25. Oakley BB, Fiedler TL, Marrazzo JM, Fredricks DN (2008) Diversity of human vaginal bacterial communities and associations with clinically defined bacterial vaginosis. Appl Environ Microbiol 74(15): 4898-4909.
26. Peix A, Ramirez-Bahena MH, Velazquez E (2009) Historical evolution and current status of the taxonomy of genus pseudomonas. Infect Genet Evol.
27. Mena KD, Gerba CP (2009) Risk assessment of pseudomonas aeruginosa in water. Rev Environ Contam Toxicol 201: 71-115.
28. Hazlett LD (2007) Bacterial infections of the cornea (pseudomonas aeruginosa). Chem Immunol Allergy 92: 185-194.
29. Franco-Vidal V, Blanchet H, Bebear C, Dutronc H, Darrouzet V (2007) Necrotizing external otitis: A report of 46 cases. Otol Neurotol 28(6): 771-773.
30. Mauldin PD, Salgado CD, Hansen IS, Durup DT, Bosso JA (2009) Attributable hospital cost and length of stay associated with healthcare associated infections caused by antibiotic-resistant, gram-negative bacteria. Antimicrob Agents Chemother.
31. Guggenheim M, Zbinden R, Handschin AE, Gohritz A, Altintas MA, et al. (2009) Changes in bacterial isolates from burn wounds and their antibiograms: A 20-year study (1986-2005). Burns 35(4): 553-560.
32. Sanchez-Carrillo C, Padilla B, Marin M, Rivera M, Cercenado E, et al. (2009) Contaminated feeding bottles: The source of an outbreak of pseudomonas aeruginosa infections in a neonatal intensive care unit. Am J Infect Control 37(2): 150-154.
33. Crivaro V, Di Popolo A, Caprio A, Lambiase A, Di Resta M, et al. (2009) Pseudomonas aeruginosa in a neonatal intensive care unit: Molecular epidemiology and infection control measures. BMC Infect Dis 9: 70.
34. Holmes C, Cervia JS, Ortolano GA, Canonica FP (2009) Preventive efficacy and cost-effectiveness of point-of-use water filtration in a subacute care unit. Am J Infect Control.
35. Trautmann M, Halder S, Hoegel J, Royer H, Haller M (2008) Point-of-use water filtration reduces endemic pseudomonas aeruginosa infections on a surgical intensive care unit. Am J Infect Control 36(6): 421-429.
36. Blanc DS, Nahimana I, Petignat C, Wenger A, Bille J, et al. (2004) Faucets as a reservoir of endemic pseudomonas aeruginosa colonization/infections in intensive care units. Intensive Care Med 30(10): 1964-1968.
37. Khachatryan ZA, Ktsoyan ZA, Manukyan GP, Kelly D, Ghazaryan KA, et al. (2008) Predominant role of host genetics in controlling the composition of gut microbiota. PLoS One 3(8): e3064.
38. Duerkop BA, Vaishnava S, Hooper LV (2009) Immune responses to the microbiota at the intestinal mucosal surface. Immunity 31(3): 368-376.
39. Slack E, Hapfelmeier S, Stecher B, Velykoredko Y, Stoel M, et al. (2009) Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science 325(5940): 617-620.
40. Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI (2005) Host-bacterial mutualism in the human intestine. Science 307(5717): 1915-1920.
41. Mestecky J, Moldoveanu Z, Smith PD, Hel Z, Alexander RC (2009) Mucosal immunology of the genital and gastrointestinal tracts and HIV-1 infection. J Reprod Immunol.
42. Sankaran S, George MD, Reay E, Guadalupe M, Flamm J, et al. (2008) Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration. J Virol 82(1): 538-545.
43. Paiardini M, Frank I, Pandrea I, Apetrei C, Silvestri G (2008) Mucosal immune dysfunction in AIDS pathogenesis. AIDS Rev 10(1): 36-46.
44. Guadalupe M, Reay E, Sankaran S, Prindiville T, Flamm J, et al. (2003) Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol 77(21): 11708-11717.
45. Wawer MJ, Makumbi F, Kigozi G, Serwadda D, Watya S, et al. (2009) Circumcision in HIV-infected men and its effect on HIV transmission to female partners in rakai, uganda: A randomised controlled trial. Lancet 374(9685): 229-237.
46. Song Y, Liu C, Finegold SM (2007) Peptoniphilus gorbachii sp. nov., peptoniphilus olsenii sp. nov., and anaerococcus murdochii sp. nov. isolated from clinical specimens of human origin. J Clin Microbiol 45(6): 1746-1752.
47. Aroutcheva A, Ling Z, Faro S (2008) Prevotella bivia as a source of lipopolysaccharide in the vagina. Anaerobe 14(5): 256-260.
48. Bostanci N, Allaker R, Johansson U, Rangarajan M, Curtis MA, et al. (2007) Interleukin-1alpha stimulation in monocytes by periodontal bacteria: Antagonistic effects of porphyromonas gingivalis. Oral Microbiol Immunol 22(1): 52-60.
49. Kim SJ, Choi EY, Kim EG, Shin SH, Lee JY, et al. (2007) Prevotella intermedia lipopolysaccharide stimulates release of tumor necrosis factor-alpha through mitogen-activated protein kinase signaling pathways in monocyte-derived macrophages. FEMS Immunol Med Microbiol 51(2): 407-413.
50. Kikkert R, Laine ML, Aarden LA, van Winkelhoff AJ (2007) Activation of tolllike receptors 2 and 4 by gram-negative periodontal bacteria. Oral Microbiol Immunol 22(3): 145-151.
51. Nadkarni MA, Martin FE, Jacques NA, Hunter N (2002) Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiology 148(Pt 1): 257-266.
52. Meyer M, Stenzel U, Hofreiter M (2008) Parallel tagged sequencing on the 454 platform. Nat Protoc 3(2): 267-278.
53. Sayers EW, Barrett T, Benson DA, Bryant SH, Canese K, et al. (2009) Database resources of the national center for biotechnology information. Nucleic Acids Res 37(Database issue): D5-15.
54. Benson DA, Karsch-Mizrachi I, Lipman DJ, Ostell J, Sayers EW (2009) GenBank. Nucleic Acids Res 37(Database issue): D26-31.
55. http://www.gideononline.com/.
56. R Development Core Team. (2009) R: A language and environment for statistical computing.
57. Goslee SC, Niering WA, Urban DL, Christensen NL (2005) Influence of environment, history and vegetative interactions on stand dynamics in a connecticut forest. J Torrey Bot Soc 132(3): 471-482.
58. Murdoch D, Chow ED (2007) Ellipse: Functions for drawing ellipses and ellipse-like confidence regions. 0.3-5.
59. Kindt R, Coe R (2005) Tree diversity analysis. A manual and software for common statistical methods for ecological and biodiversity studies. Nairobi: World Agroforestry Centre (ICRAF).
60. Bray JR, Curtis JT (1957) An ordination of the upland forest communities of southern wisconsin. Ecol Monogr 27(4): 326-349.
61. Faith DP, Minchin PR, Belbin L (1987) Compositional dissimilarity as a robust measure of ecological distance. Vegetatio 69(1-3): 57-68.
62. Oksanen J, Kindt R, Legendre P, O'Hara B, Simpson GL, et al. (2009) Vegan: Community ecology package. 1.15-2.
63. Lau MK (2009) DiversitySampler: Functions for re-sampling a community matrix to compute shannon's diversity index at different sampling levels. 1.0.
64. Anderson MJ (2001) A new method for non-parametric multivariate analysis of variance. Austral Ecol 26(1): 32-46.
65. Dufrene M, Legendre P (1997) Species assemblages and indicator species: The need for a flexible asymmetrical approach. Ecol Monogr 67(3): 345-366.
66. Roberts DW (2007) Labdsv: Ordination and multivariate analysis for ecology. 1.3-1.
67. Kendall MG (1938) A new measure of rank correlation. Biometrika 30: 81-93.